复发性-话题@MedSci

#复发性#

452篇内容 | 2479人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909648, encodeId=8d44190964886, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Gynecol Oncol：含贝伐单抗方案在复发性低级别浆液性卵巢癌及腹膜癌中的应用, objectType=article, longId=105965, objectId=a7191059651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7191059651f, replyNumber=0, likeNumber=99, createdTime=2017-09-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7191059651f, moduleTitle=Gynecol Oncol：含贝伐单抗方案在复发性低级别浆液性卵巢癌及腹膜癌中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7191059651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909638, encodeId=1dff190963854, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：Nivolumab一线用于IV期及复发性非小细胞肺癌, objectType=article, longId=102940, objectId=349e1029401f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=349e1029401f, replyNumber=0, likeNumber=55, createdTime=2017-08-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=349e1029401f, moduleTitle=NEJM：Nivolumab一线用于IV期及复发性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=349e1029401f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909675, encodeId=a30319096e5ed, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=基因治疗有望在复发性脑肿瘤治疗中发挥作用, objectType=article, longId=118077, objectId=616d1180e707, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616d1180e707, replyNumber=0, likeNumber=66, createdTime=2018-08-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616d1180e707, moduleTitle=基因治疗有望在复发性脑肿瘤治疗中发挥作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616d1180e707)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909671, encodeId=076919096e181, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：Venetoclax靶向治疗复发性/难治性多发性骨髓瘤的效果。, objectType=article, longId=116042, objectId=be9211604209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be9211604209, replyNumber=0, likeNumber=75, createdTime=2018-03-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be9211604209, moduleTitle=Blood：Venetoclax靶向治疗复发性/难治性多发性骨髓瘤的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be9211604209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909707, encodeId=e5b51909e0776, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, objectType=article, longId=132551, objectId=bc0a132551d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0a132551d5, replyNumber=0, likeNumber=93, createdTime=2018-04-27, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0a132551d5, moduleTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0a132551d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909678, encodeId=3f2719096e8f6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA：Ipilimumab对于人乳头瘤相关的转移或复发性宫颈癌疗效如何？, objectType=article, longId=121085, objectId=c15d121085ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15d121085ce, replyNumber=0, likeNumber=65, createdTime=2018-06-14, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15d121085ce, moduleTitle=JAMA：Ipilimumab对于人乳头瘤相关的转移或复发性宫颈癌疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15d121085ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909702, encodeId=fa201909e026e, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, objectType=article, longId=130441, objectId=33e2130441cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e2130441cc, replyNumber=0, likeNumber=55, createdTime=2018-07-10, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e2130441cc, moduleTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e2130441cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909659, encodeId=5eb419096598b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JCO：rAd-IFNα/Syn3可用于治疗BCG难治性或复发性高度非肌肉侵入性膀胱癌！, objectType=article, longId=111077, objectId=78d81110e7ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d81110e7ef, replyNumber=0, likeNumber=80, createdTime=2018-02-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d81110e7ef, moduleTitle=JCO：rAd-IFNα/Syn3可用于治疗BCG难治性或复发性高度非肌肉侵入性膀胱癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d81110e7ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909666, encodeId=da4519096667b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Eur J Ophthalmol：玻璃体切除术是儿科复发性葡萄膜炎的抗炎治疗的有效手段！, objectType=article, longId=112184, objectId=28471121841a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28471121841a, replyNumber=0, likeNumber=55, createdTime=2017-10-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28471121841a, moduleTitle=Eur J Ophthalmol：玻璃体切除术是儿科复发性葡萄膜炎的抗炎治疗的有效手段！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28471121841a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909684, encodeId=ae48190968428, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。, objectType=article, longId=123377, objectId=c3d71233e7a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3d71233e7a0, replyNumber=0, likeNumber=80, createdTime=2018-01-23, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3d71233e7a0, moduleTitle=Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3d71233e7a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909641, encodeId=c2e019096417c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncology:Gilteritinib或能有效治疗复发性AML, objectType=article, longId=103464, objectId=ac2b1034647b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac2b1034647b, replyNumber=0, likeNumber=63, createdTime=2017-11-10, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac2b1034647b, moduleTitle=Lancet Oncology:Gilteritinib或能有效治疗复发性AML, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac2b1034647b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909696, encodeId=90461909696d3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=罗氏旗下奥美珠单抗经欧盟批准用于复发性及进展性多发性硬化症的治疗, objectType=article, longId=128053, objectId=0dba1280537c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dba1280537c, replyNumber=0, likeNumber=69, createdTime=2018-06-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dba1280537c, moduleTitle=罗氏旗下奥美珠单抗经欧盟批准用于复发性及进展性多发性硬化症的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dba1280537c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909658, encodeId=ab9f1909658b6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：卡非佐米和硼替佐米用于复发性或难治性多发性骨髓瘤的疗效对比。, objectType=article, longId=110731, objectId=c503110e3112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c503110e3112, replyNumber=0, likeNumber=82, createdTime=2017-10-23, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c503110e3112, moduleTitle=Lancet oncol：卡非佐米和硼替佐米用于复发性或难治性多发性骨髓瘤的疗效对比。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c503110e3112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909642, encodeId=532919096421c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：联合新一代CD38单抗与免疫调节药物有望更好的抑制复发性骨髓瘤, objectType=article, longId=103526, objectId=94cf103526e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94cf103526e1, replyNumber=0, likeNumber=85, createdTime=2018-04-15, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94cf103526e1, moduleTitle=Blood：联合新一代CD38单抗与免疫调节药物有望更好的抑制复发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94cf103526e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909705, encodeId=cc881909e05cf, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, objectType=article, longId=132424, objectId=a7f51324240d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f51324240d, replyNumber=0, likeNumber=60, createdTime=2018-06-20, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f51324240d, moduleTitle=Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f51324240d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909697, encodeId=925a190969e06, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Thromb Haemost：轻度抗凝血酶缺乏症与复发性静脉血栓栓塞风险！, objectType=article, longId=128280, objectId=f8711282802f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8711282802f, replyNumber=0, likeNumber=65, createdTime=2018-10-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8711282802f, moduleTitle=J Thromb Haemost：轻度抗凝血酶缺乏症与复发性静脉血栓栓塞风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8711282802f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909685, encodeId=96901909685f8, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Mayo Clin Proc：接受细胞毒性化疗的癌症患者：FMT治疗复发性CDI效果如何？, objectType=article, longId=124718, objectId=6da3124e1862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6da3124e1862, replyNumber=0, likeNumber=72, createdTime=2018-03-15, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6da3124e1862, moduleTitle=Mayo Clin Proc：接受细胞毒性化疗的癌症患者：FMT治疗复发性CDI效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6da3124e1862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909647, encodeId=5c4b190964e35, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？, objectType=article, longId=105796, objectId=9a0d105e965e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0d105e965e, replyNumber=0, likeNumber=69, createdTime=2018-03-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0d105e965e, moduleTitle=Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a0d105e965e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909663, encodeId=177d1909663e5, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=eLife：研究人员开发出治疗复发性乳腺癌的新药！, objectType=article, longId=111510, objectId=122f111510eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122f111510eb, replyNumber=0, likeNumber=56, createdTime=2018-06-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122f111510eb, moduleTitle=eLife：研究人员开发出治疗复发性乳腺癌的新药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122f111510eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909650, encodeId=b8791909650cc, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗, objectType=article, longId=106877, objectId=eba21068e7a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eba21068e7a6, replyNumber=0, likeNumber=59, createdTime=2017-12-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba21068e7a6, moduleTitle=Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eba21068e7a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Gynecol Oncol：含贝伐单抗方案在复发性低级别浆液性卵巢癌及腹膜癌中的应用

2017-09-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：Nivolumab一线用于IV期及复发性非小细胞肺癌

2017-08-07

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

基因治疗有望在复发性脑肿瘤治疗中发挥作用

2018-08-16

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：Venetoclax靶向治疗复发性/难治性多发性骨髓瘤的效果。

2018-03-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估

2018-04-27

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA：Ipilimumab对于人乳头瘤相关的转移或复发性宫颈癌疗效如何？

2018-06-14

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？

2018-07-10

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JCO：rAd-IFNα/Syn3可用于治疗BCG难治性或复发性高度非肌肉侵入性膀胱癌！

2018-02-16

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Eur J Ophthalmol：玻璃体切除术是儿科复发性葡萄膜炎的抗炎治疗的有效手段！

2017-10-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：Venetoclax用于进行过依鲁替尼治疗的复发性/难治性慢性淋巴细胞白血病的疗效和安全性。

2018-01-23

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncology:Gilteritinib或能有效治疗复发性AML

2017-11-10

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

罗氏旗下奥美珠单抗经欧盟批准用于复发性及进展性多发性硬化症的治疗

2018-06-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：卡非佐米和硼替佐米用于复发性或难治性多发性骨髓瘤的疗效对比。

2017-10-23

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：联合新一代CD38单抗与免疫调节药物有望更好的抑制复发性骨髓瘤

2018-04-15

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Ann Rheum Dis：生物制剂治疗复发性多软骨炎的疗效和安全性

2018-06-20

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Thromb Haemost：轻度抗凝血酶缺乏症与复发性静脉血栓栓塞风险！

2018-10-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Mayo Clin Proc：接受细胞毒性化疗的癌症患者：FMT治疗复发性CDI效果如何？

2018-03-15

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Leuk Lymphoma：地西他滨单药治疗复发性/难治性AML 疗效几何？

2018-03-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

eLife：研究人员开发出治疗复发性乳腺癌的新药！

2018-06-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗

2017-12-07

科室
- - 订阅+
  - 更多科室
工具
服务